Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>To the authors' knowledge, information regarding whether daily bathing with chlorhexidine gluconate (CHG) reduces central line–associated bloodstream infection (CLABSI) in pediatric oncology patients and those undergoing hematopoietic stem cell transplantation (HCT) is limited.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>In the current multicenter, randomized, double‐blind, placebo‐controlled trial, patients aged ≥2 months and <22 years with cancer or those undergoing allogeneic HCT were randomized 1:1 to once‐daily bathing with 2% CHG‐impregnated cloths or control cloths for 90 days. The primary outcome was CLABSI. Secondary endpoints included total positive blood cultures, acquisition of resistant organisms, and acquisition of cutaneous staphylococcal isolates with an elevated CHG mean inhibitory concentration.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The study was stopped early because of poor accrual. Among the 177 enrolled patients, 174 were considered as evaluable (88 were randomized to the CHG group and 86 were randomized to the control group). The rate of CLABSI per 1000 central line days in the CHG group was 5.44 versus 3.10 in the control group (risk difference, 2.37; 95% confidence interval, 0.05‐4.69 [<i>P</i> = .049]). Post hoc conditional power analysis demonstrated a 0.2% chance that the results would have favored CHG had the study fully enrolled. The rate of total positive blood cultures did not differ between groups (risk difference, 2.37; 95% confidence interval, −0.41 to 5.14 [<i>P</i> = .078]). The number of patients demonstrating the new acquisition of resistant organisms did not differ between groups (<i>P</i> = .54). Patients in the CHG group were found to be more likely to acquire cutaneous staphylococcal isolates with an elevated CHG mean inhibitory concentration (<i>P</i> = .032). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The data from the current study do not support the use of routine CHG bathing in children with cancer or those undergoing allogeneic HCT.</p></section>

Exploring facilitators and barriers to daily chlorhexidine gluconate bathing in adult patients undergoing hematopoietic stem cell transplantation

Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation

Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem cell transplantation: A double‐blinded randomized controlled trial from the Children's Oncology Group

Implementing an Oral Health Educator Contributes to Reduced MBI-CLABSI Rates for Pediatric Hematopoietic Stem Cell Transplant Patients

Time limitations and the challenge of providing infection-preventing dental care to hematopoietic stem-cell transplantation patients

Oral health and hematopoietic stem cell transplantation: A longitudinal evaluation of the first 28 days

Microbiota dynamics in a randomized trial of gut decontamination during allogeneic hematopoietic cell transplantation

Make Sure You Have a Safety Net: Updates in the Prevention and Management of Infectious Complications in Stem Cell Transplant Recipients

A Biobehavioral Perspective on Caring for Allogeneic Hematopoietic Stem Cell Transplant Survivors with Graft-Versus-Host Disease

[Key microbial monitoring and clinical analysis of bloodstream infections and CRO colonization after hematopoietic stem cell transplantation in hematological patients]

Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation

Transitions of Care: A Hematopoietic Stem Cell Transplantation Nursing Education Project Across the Trajectory

Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation

Progress Towards Improving Homing and Engraftment of Hematopoietic Stem Cells for Clinical Transplantation

Effectiveness of Bath Wipes After Hematopoietic Cell Transplantation: A Randomized Trial

Social determinants of health predict health outcomes following pediatric allogeneic hematopoietic stem cell transplant

An Integrative Review of Patient Education During Inpatient Hematopoietic Stem Cell Transplantation

Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

SOHO State of the Art Updates and Next Questions ࣦ CTLs for Infections Following Stem Cell Transplantation

Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual

A prospective study of the relationship between illness perception, depression, anxiety, and quality of life in hematopoietic stem cell transplant patients